Qiu Zhang
Corporate Officer/Principal bij Dong Ying (Jiangsu) Pharmaceuticals Co.,Ltd.
Actieve functies van Qiu Zhang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Dong Ying (Jiangsu) Pharmaceuticals Co.,Ltd.
 Dong Ying (Jiangsu) Pharmaceuticals Co.,Ltd. Pharmaceuticals: MajorHealth Technology Part of Shanghai Pharmaceuticals Holding Co., Ltd., Dong Ying (Jiangsu) Pharmaceuticals Co.,Ltd. develops and manufactures pharmaceutical products. Dong Ying (Jiangsu) Pharmaceuticals Co.,Ltd. was acquired by Big Global Ltd., part of Shanghai Pharmaceuticals Holding Co., Ltd. from July 01, 2013 on December 10, 2007 for $0.0 million. | Corporate Officer/Principal | 14-04-2011 | - |
Loopbaan van Qiu Zhang
Eerdere bekende functies van Qiu Zhang
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NANJING HICIN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | 01-12-2007 | 01-12-2007 |
| Jilin Weiwei Group | Corporate Officer/Principal | 01-10-2003 | 01-10-2003 |
Opleiding van Qiu Zhang
| Shenyang Pharmaceutical University | Undergraduate Degree |
| Jilin Institute of Chemical Technology | Undergraduate Degree |
Statistieken
Internationaal
| China | 6 |
Operationeel
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NANJING HICIN PHARMACEUTICAL CO., LTD. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
| Jilin Weiwei Group | |
Dong Ying (Jiangsu) Pharmaceuticals Co.,Ltd.
Dong Ying (Jiangsu) Pharmaceuticals Co.,Ltd. Pharmaceuticals: MajorHealth Technology Part of Shanghai Pharmaceuticals Holding Co., Ltd., Dong Ying (Jiangsu) Pharmaceuticals Co.,Ltd. develops and manufactures pharmaceutical products. Dong Ying (Jiangsu) Pharmaceuticals Co.,Ltd. was acquired by Big Global Ltd., part of Shanghai Pharmaceuticals Holding Co., Ltd. from July 01, 2013 on December 10, 2007 for $0.0 million. | Health Technology |
